What is the Current Share Price of Dr Reddys Laboratories Ltd?
- Answer Field
-
Dr Reddys Laboratories Ltd share price is for NSE ₹ 1,151.70 & for BSE ₹ 1,152.60 as on Jul 24 2026 03:30 PM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
DR. REDDY S LABORATORIES is currently trading at ₹1151.7, down by ₹14.6 from the previous close. The stock touched an intraday high of ₹1166.30 and a low of ₹1131.40 during the latest trading session. Over the past one year, DR. REDDY S LABORATORIES has delivered a loss of 8.99%, while the stock has declined 13.3% in the last one month.
| Particulars | JUN 2026 (Values in Cr) |
|---|---|
| Revenue | 5115.00 |
| Operating Expense | 5080.00 |
| Net Profit | 404.70 |
| Net Profit Margin (%) | 7.91 |
| Earnings Per Share (EPS) | 4.86 |
| EBITDA | 887.80 |
| Effective Tax Rate (%) | 18.57 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.45 | 13.46 | 1.57 | 248.68 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD | 463.55 | 37.26 | 4.12 | 4916.24 | 118.35 | 552.90 |
| CIPLA LTD. | 1410.90 | 31.85 | 3.31 | 113978.90 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LTD. | 432.60 | 20.23 | 3.13 | 1273.18 | 256.40 | 480.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.45 | 22.69 | 4.18 | 248.68 | 23.12 | 38.85 |
| AMRUTANJAN HEALTH CARE LTD. | 510.50 | 22.88 | 3.98 | 1475.89 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA IND LT | 8000.10 | 104.55 | 22.91 | 20000.25 | 7630.00 | 9850.00 |
| BLISS GVS PHARMA LTD | 463.55 | 50.11 | 4.25 | 4916.24 | 118.35 | 552.90 |
Dr. Reddy’s Laboratories posted consolidated sales of ₹8,572 crore in Q1 FY25-26 versus ₹7,696 crore in Q1 FY24-25. Expenses stood at ₹6,398 crore in Q1 FY25-26 against ₹5,566 crore in Q1 FY24-25. Operating profit was ₹2,174 crore in Q1 FY25-26 compared with ₹2,130 crore in Q1 FY24-25. Net profit was recorded at ₹1,410 crore in Q1 FY25-26 versus ₹1,392 crore in Q1 FY24-25.
Date Source: screener.in, and corporate filings on NSE/BSE
Dr. Reddy’s Laboratories reported consolidated sales of ₹32,644 crore in FY24-25 versus ₹28,011 crore in FY23-24. Expenses stood at ₹24,097 crore in FY24-25 against ₹20,078 crore in FY23-24. Operating profit was ₹8,547 crore in FY24-25 compared with ₹7,933 crore in FY23-24. Net profit was recorded at ₹5,725 crore in FY24-25 versus ₹5,578 crore in FY23-24.
Date Source: screener.in, and corporate filings on NSE/BSE
Dr. Reddy’s Laboratories paid a dividend of ₹8 per share with ex-date of 10 Jul 2025. In the previous year, the company paid ₹40 per share on 16 Jul 2024. Earlier, it paid ₹40 per share on 11 Jul 2023, ₹30 per share on 11 Jul 2022, ₹25 per share on 9 Jul 2021, ₹25 per share on 13 Jul 2020, and ₹20 per share on 15 Jul 2019.
Date Source: screener.in, and corporate filings on NSE/BSE
Sign-in to trade with your demat account, or set up a new demat account for free
Dr Reddys Laboratories Ltd share price is for NSE ₹ 1,151.70 & for BSE ₹ 1,152.60 as on Jul 24 2026 03:30 PM.
The market cap of Dr Reddys Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 24 2026 03:30 PM.
The 52 Week High and Low of Dr Reddys Laboratories Ltd for NSE is ₹ 1,414.90 and ₹ 1,101.00 and for BSE is ₹ 1,414.40 and ₹ 1,080.05.
The 1 year returns on the stock has been -8.99%.
As on Jul 24 2026 03:30 PM the price-to-earnings (PE) ratio for Dr Reddys Laboratories Ltd share is 144.98.
As on Jul 24 2026 03:30 PM, the price-to-book (PB) ratio for Dr Reddys Laboratories Ltd share is 377.95.
You can trade in Dr Reddys Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Dr Reddys Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Dr Reddys Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found